The emerging era of pharmacogenomics: current successes, future potential, and challenges.

Lee, J W; Aminkeng, F; Bhavsar, A P; Shaw, K; Carleton, B C; Hayden, M R; Ross, C J D

Lee, J W; Aminkeng, F; Bhavsar, A P; Shaw, K; Carleton, B C; Hayden, M R; Ross, C J D.

Affiliation

Lee JW; Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada; Child & Family Research Institute, Vancouver, BC, Canada.

Clin Genet ; 86(1): 21-8, 2014 Jul.

Article in En | MEDLINE | ID: mdl-24684508

Subject(s)

Biomarkers, Pharmacological; Genetic Testing/methods; Genetic Variation; Pharmacogenetics/methods; Pharmacogenetics/trends; Precision Medicine/methods; Anthracyclines/pharmacology; Carbamazepine/pharmacology; Cisplatin/pharmacology; Codeine/pharmacology; Humans; Precision Medicine/trends; Warfarin/pharmacology

Key words

ADRs; adverse drug reactions; anthracycline; carbamazepine; cisplatin; codeine; pharmacogenomics; warfarin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Genetic Variation / Genetic Testing / Biomarkers, Pharmacological / Precision Medicine Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Genet Year: 2014 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google